I
Ionis Pharmaceuticals, Inc. (IONS)
NMS – Real vaqt narxi. Valyuta: USD
75.83
+0.45 (0.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
75.48
-0.35 (-0.46%)
Bozor oldidan: May 13, 2026, 8:32 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
75.83
+0.45 (0.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
75.48
-0.35 (-0.46%)
Bozor oldidan: May 13, 2026, 8:32 AM EDT
This stock has a consensus price target of $91.50 based on the ratings of 25 analysts. The high is $130.00 and the low is $39.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 39 | $ 91.5 | $ 130 |
| O’zgarish | -48.57% | 20.66% | 71.44% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-30 | 32.48% | RBC Capital | $95 → $100 | Maintains | Outperform |
| 2026-04-30 | 52.35% | Barclays | $106 → $115 | Maintains | Overweight |
| 2026-04-30 | 65.6% | HC Wainwright & Co. | $120 → $125 | Maintains | Buy |
| 2026-04-23 | 43.08% | TD Cowen | $110 → $108 | Maintains | Buy |
| 2026-04-21 | 45.73% | Canaccord Genuity | $110 | Initiates Coverage On | Buy |